Skip to main content
. 2016 Jul 28;115(6):649–654. doi: 10.1038/bjc.2016.222

Table 2. Treatment duration and dose modifications.

Cycles Number
Median 6
Range 1–31
>3 77
3 4
2 9
1 12
Dose modifications n (%)
Started with full dose of all drugs 33 (32.4)
Started with reduced dose of 1 or more drugs 69 (67.6)
Reduction or omission of 5-FU bolus 93%
Reduction in irinotecan 88%
Reduction in oxaliplatin 68%
Reduction infusional 5-FU 66%